Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Investigational New Drug (IND) Applications: 4 Common Mistakes By Premier Research September 19, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 6: Measuring the Placebo Response By Scott Millard September 13, 2017 Consulting 6 Tips for Strategic CRO-Sponsor Partnerships (And Why They’re Important) By Krista Armstrong September 12, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 5: The Placebome By Scott Millard September 7, 2017 Consulting 7 New and Emerging Acne Treatments By Premier Research September 6, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 4: Neurobiological Mechanisms By Scott Millard August 30, 2017 Previous 1 …39 40 41 42 43 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today